Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP)
Clinical trial NCT02216084 · COMPLETED
Trial details
- NCT number
- NCT02216084
- Sponsor
- Baxalta now part of Shire
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-30
- Primary completion
- 2016-02-22
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.